Nephros (NEPH) Corporate presentation summary

Business overview and market position

• Provides advanced water filtration solutions for healthcare, hospitality, government, and manufacturing sectors.

• Offers FDA-cleared Class II products for infection control and dialysis water, supporting both medical and commercial applications.

• Proprietary hollow-fiber membrane technology enables effective removal of bacteria, viruses, endotoxins, and microplastics.

• Recurring revenue model with programmatic customers and strong regulatory tailwinds from ASHRAE, AAMI, and NSF standards.

• Maintains a strong balance sheet with no debt and positive cash flow.

Leadership and governance

• Led by an experienced executive team with backgrounds in product management, finance, and strategic accounts.

• Board includes professionals with expertise in private equity, healthcare, finance, and operations.

Product segments and technology

• Focuses on two main markets: medical (infection control, dialysis) and commercial filtration.

• Medical filters are FDA 510(k)-cleared, providing sub-micron purification and long filter life for infection control and dialysis.

• Commercial filters reduce contaminants like lead, PFAS, and scale, improving equipment performance.

• New developments include nano- and microplastic removal and digital tools for tracking and monitoring filter usage.